Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-15-000013
Filing Date
2015-04-02
Accepted
2015-04-02 16:27:29
Documents
1
Period of Report
2015-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_142800643929090.html 4  
1 FORM 4 wf-form4_142800643929090.xml 4 4016
  Complete submission text file 0001288123-15-000013.txt   5479
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Issuer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTIGENICS INC. 162 FIFTH AVENUE, SUITE 900 NEW YORK NY 10010
Business Address
DECHAENE TOM (Reporting) CIK: 0001222092 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 15748057